Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

ClinicalTrials.gov ID: NCT03337620

Public ClinicalTrials.gov record NCT03337620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel 20 Week Study of the Efficacy and Safety of the Tx360® Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

Study identification

NCT ID
NCT03337620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Tian Medical Inc.
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

  • Tx360 Device

Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2017
Primary completion
Nov 14, 2023
Completion
Dec 28, 2023
Last update posted
Jan 4, 2024

2017 – 2023

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Yale University New Haven Connecticut 06519
New England Institute for Clinical Research Stamford Connecticut 06905
Eisenhower Army Medical Center Fort Gordon Georgia 30905
Crescent City Headache and Neurology Centre Chalmette Louisiana 70043
MedVadis Research Watertown Massachusetts 02472
Clinvest Research, LLC Springfield Missouri 65810
Hudson Medical New York New York 10007
North Suffolk Neurology, PC Port Jefferson Station New York 11776
Womack Army Medical Senter Fort Bragg North Carolina 28310
Preferred Primary Care Physicians Pittsburgh Pennsylvania 15236
Lone Star Neurology Frisco Texas 75035

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03337620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03337620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →